Recipients to be followed-up for 3 months after 2nd dose of Covaxin, ICMR issues guidelines

The Indian Council of Medical Research (ICMR) in its guidelines for the vaccination drive said the recipients of ‘Covaxin’ COVID-19 vaccine will remain at the vaccination site for at least 30 minutes under observation to record any adverse event. The recipients will be followed-up for a period of three months after the second dose of vaccination, it added.

A Standard Operating Procedure (SoP) has been issued by ICMR for the restricted use authorisation of Covaxin under clinical trial mode. In case of severe/serious adverse event at any given point of time after vaccination, the recipient will report to the nearest health facility for treatment and will also inform the designated vaccinator.

Advertisement

“He/she will return to the session site on day 28 or on the date given to him/her for the 2nd dose of Covaxin. All the vaccine recipients will be followed-up for a period of 3 months after the second dose of vaccination,” the SoPs stated.

The individuals with the following conditions will not be eligible for vaccination — have any history of allergies, have a fever, bleeding disorder or are on a blood thinner, are immunocompromised, or are on a medicine that affects their immune system, pregnant, breastfeeding, have received another COVID-19 vaccine, any other serious health-related issues as determined by the Vaccinator/Officer supervising vaccination.